|
000
| 01183cam 2200253za 4500 |
|---|
| 001 | 9.688058 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20220121105651 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150407s2007 onc o f000 0 eng d |
|---|
| 020 | |a0-662-42506-5 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH169-4/2006E-PDF |
|---|
| 110 | 1 |aCanada. |bHealth Products and Food Branch. |
|---|
| 245 | 10|aGuidance for industry - priority review of drug submissions |h[electronic resource] |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |c2007. |
|---|
| 300 | |a25p. |
|---|
| 500 | |aThe catalogue number (H169-4/2006E) and ISBN (0-662-42505-7) for the print edition have been incorrectly copied in this electronic version. "Date Adopted 2002/09/16 Revised Date 2005/11/30 Effective Date 2006/03/01 Administrative Changes Date 2007/12/20" |
|---|
| 590 | |a12-42-Supp|b2012-11-21 |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 775 | 08|tLigne directrice à l'intention de l'industrie - évaluation prioritaire des présentations de drogues |w(CaOODSP)9.632493 |
|---|
| 794 | |tGuidance for industry : |b2009|w(CaOODSP)9.907191 |
|---|
| 856 | 40|qPDF|s93 KB|uhttps://publications.gc.ca/collections/collection_2012/sc-hc/H169-4-2006-eng.pdf |
|---|